ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 119,14
0,33%
Dow Jones
39 671,04
-0,51%
DAX
18 732,72
0,27%
Brent Oil
81,565
0,04%
Bitcoin
69 682,64
0,84%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Evolus Inc (EOLS)

  7. Evolus Inc (EOLS) Actualités

EOLS

Evolus (EOLS)

Evolus Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:EOLS
DateHeureSourceTitreSymboleSociété
20/05/202414h30Business WireEvolus Announces Positive Data from Pivotal Trial for First Two Evolysse™ Dermal Filler Products at 2024 SCALE MeetingNASDAQ:EOLSEvolus Inc
15/05/202423h19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EOLSEvolus Inc
15/05/202414h30Business WireEvolus Celebrates Fifth Anniversary of Launching its Flagship Product Jeuveau® at the Women’s Wear Daily Beauty CEO SummitNASDAQ:EOLSEvolus Inc
15/05/202402h06Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:EOLSEvolus Inc
11/05/202400h55Business WireEvolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:EOLSEvolus Inc
10/05/202415h10Business WireEvolus’ Sandra Beaver Named Orange County Business Journal’s Public Company CFO of the YearNASDAQ:EOLSEvolus Inc
07/05/202423h00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:EOLSEvolus Inc
07/05/202422h14Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EOLSEvolus Inc
07/05/202422h05Business WireEvolus Reports First Quarter 2024 Results and Provides Business UpdateNASDAQ:EOLSEvolus Inc
23/04/202422h30Business WireEvolus to Report First Quarter Financial Results on May 7, 2024NASDAQ:EOLSEvolus Inc
17/04/202422h05Business WireEvolus Announces Publication of Safety and Duration Data from Phase 2 Study for “Extra-Strength” 40U Formulation of Jeuveau®NASDAQ:EOLSEvolus Inc
26/03/202413h00Business WireEvolus to Participate in the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:EOLSEvolus Inc
11/03/202414h00Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:EOLSEvolus Inc
11/03/202412h00Business WireEvolus Announces Pricing of $50.0 Million Underwritten Offering of Common StockNASDAQ:EOLSEvolus Inc
07/03/202422h58Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:EOLSEvolus Inc
07/03/202422h42Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:EOLSEvolus Inc
07/03/202422h05Business WireEvolus Reports Record Fourth Quarter and Full Year 2023 Financial Results; Reaffirms 2024 GuidanceNASDAQ:EOLSEvolus Inc
01/03/202414h30Business WireEvolus Announces Results from European Head-to-Head Filler TrialNASDAQ:EOLSEvolus Inc
27/02/202414h30Business WireEvolus to Participate in Upcoming Leerink Partners and Barclays Investor ConferencesNASDAQ:EOLSEvolus Inc
22/02/202422h30Business WireEvolus to Report Fourth Quarter and Year End 2023 Results and Provide Business Update on March 7, 2024NASDAQ:EOLSEvolus Inc
16/01/202423h28Business WireEvolus Announces Preliminary Unaudited Fourth Quarter and Full-Year 2023 Net Revenue, Achieving Record Results and Exceeding Expectations; Issues 2024 GuidanceNASDAQ:EOLSEvolus Inc
11/01/202412h18IH Market NewsWall Street Highlights: Mastercard’s Financial Rise, Citigroup’s $3.8 Billion Charges, and MoreNASDAQ:EOLSEvolus Inc
04/01/202422h05Business WireEvolus Announces the Appointment of Nareg Sagherian to Vice President, Head of Global Investor Relations and Corporate CommunicationsNASDAQ:EOLSEvolus Inc
20/12/202314h00Business WireEvolus Enters into Licensing Agreement with Symatese to Exclusively Distribute Next-Generation Dermal Fillers in EuropeNASDAQ:EOLSEvolus Inc
12/12/202311h50IH Market NewsHasbro Job Cuts, Oracle’s Stock Decline, Google’s Epic Antitrust Loss, and MoreNASDAQ:EOLSEvolus Inc
07/11/202322h16Business WireEvolus Reports Record Third Quarter 2023 Financial Results and Phase II Data for Extra-Strength 40U Formulation of Jeuveau®NASDAQ:EOLSEvolus Inc
06/11/202314h45Business Wire“Extra-Strength” 40U Formulation of Jeuveau® Demonstrates Effects Lasting 26 Weeks in Phase II Data Presented at 2023 ASDS Annual MeetingNASDAQ:EOLSEvolus Inc
01/11/202313h45Business WireEvolus to Participate in November Investor ConferencesNASDAQ:EOLSEvolus Inc
25/10/202314h45Business WireFinal Phase 2 Data Evaluating 40U Dose of PrabotulinumtoxinA-xvfs to be Presented at 2023 ASDS Annual MeetingNASDAQ:EOLSEvolus Inc
25/10/202314h45Business WireEvolus to Report Third Quarter 2023 ResultsNASDAQ:EOLSEvolus Inc
 Showing the most relevant articles for your search:NASDAQ:EOLS

Dernières Valeurs Consultées

BIT
P1W981
NLBNPIT1W981 20240621 0.3
EU
XS2421195178
ING Groep NV Inggr0.975%...
LSE
XGID
Xgbl Infra Sw
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés